Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Alfonso, Berrocal"'
Autor:
Maria Gonzalez-Cao, Clara Mayo de las Casas, Juana Oramas, Miguel A. Berciano-Guerrero, Luis de la Cruz, Pablo Cerezuela, Ana Arance, Eva Muñoz-Couselo, Enrique Espinosa, Teresa Puertolas, Roberto Diaz Beveridge, Sebastian Ochenduszko, Maria-Jose Villanueva, Laura Basterretxea, Lorena Bellido, Delvys Rodriguez, Begoña Campos, Clara Montagut, Ana Drozdowskyj, Miguel A. Molina, Jose Antonio Lopez-Martin, Alfonso Berrocal
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Whether intermittent strategies of delivering drugs can improve cancer patients survival is still unclear. Here, the authors reports the results of a randomized phase II clinical trial aimed to compare the efficacy and safety of two dosing regimens (
Externí odkaz:
https://doaj.org/article/bcf9c314e06143fd83f1b0b564d0166e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Caroline Robert, Helena Escuin-Ordinas, Juan Martin-Liberal, Miguel Sanmamed, Stephane Dalle, Ana Arance, Marya Chaney, Sorilla Prey, Alfonso Berrocal, Caroline Dutriaux, Iván Márquez Rodas, Philippe Saiag, Luis de la Cruz Merino, Juan Rodríguez-Moreno, Eduardo Castañón Álvarez, Pablo Cerezuela-Fuentes, Henry Montaudie, María González Cao, Julie Charles, María Pilar López Criado, Enrique de Miguel, Elisa Funk-Brentano, Roberto Huertas, Delvys Rodríguez Abreu, Eva Muñoz Couselo, Javier Sánchez López, Sonia Maciá
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/cfa232992c194eb9b490f0ff34e0deec
Autor:
Enriqueta Felip, Mario Sznol, Harriet Kluger, Erin Filbert, Valentina Boni, Montaser Shaheen, Nicholas Iannotti, Delvys Rodriguez-Abreu, Maria Gonzalez-Cao, Alfonso Berrocal, Ralph Hauke, Lynn Schuchter, Gerald Linette, Sarah Weiss, Miguel-Ángel Berciano-Guerrero, Ana Maria Arance, Apar Kishor Ganti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/486cee47556042ac976f547e0220656d
Autor:
José Luis Manzano, Ivan Marquez-Rodas, Cristina Carrera, Mario Mandala, Eva Muñoz-Couselo, Maria Gonzalez-Cao, Teresa Puertolas, Mar Riveiro, Carolina Ortiz, Roger Paredes, Daniel Podzamczer, Jose Molto, Boris Revollo, Lourdes Mateu, Sara Fancelli, Enrique Espinosa, Bonaventura Clotet, Javier Martinez-Picado, Pablo Cerezuela, Ainara Soria, Alfonso Berrocal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown durable clinical benefit and survival improvement in melanoma and other tumo
Externí odkaz:
https://doaj.org/article/9b4da5993e134c378f9c571d2ea5242c
Autor:
Ana Arance, Luis de la Cruz-Merino, Teresa M. Petrella, Rahima Jamal, Lars Ny, Ana Carneiro, Alfonso Berrocal, Ivan Márquez-Rodas, Anna Spreafico, Victoria Atkinson, Fernanda Costa Svedman, Andrew Mant, Muhammad A. Khattak, Catalin Mihalcioiu, Sekwon Jang, C. Lance Cowey, Alan D. Smith, Natalyn Hawk, Ke Chen, Scott J. Diede, Clemens Krepler, Georgina V. Long
Publikováno v:
Journal of Clinical Oncology. 41:75-85
PURPOSE Effective treatments are needed for melanoma that progresses on inhibitors of programmed cell death protein-1 (PD-1) or its ligand (PD-L1). We conducted the phase II LEAP-004 study to evaluate the combination of the multikinase inhibitor lenv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cd623f471c8b6c65cf93989485507a8
https://doi.org/10.1200/jco.22.00221
https://doi.org/10.1200/jco.22.00221
Autor:
María Martínez-García, Sonia Servitja Tormo, Noelia Vilariño Quintela, Ana Arance Fernández, Alfonso Berrocal Jaime, Blanca Cantos Sánchez de Ibargüen, Sonia Del Barco Berrón, Rosario García Campelo, Regina Gironés Sarrió, Juan Manuel Sepúlveda-Sánchez
Publikováno v:
CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Central nervous system (CNS) dissemination is a severe complication in cancer and a leading cause of cancer-related mortality. Brain metastases (BMs) are the most common types of malignant intracranial tumors and are reported in approximately 25% of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ee9cac1c905a449b5d970703a1102b
https://doi.org/10.1007/s12094-022-02803-0
https://doi.org/10.1007/s12094-022-02803-0
Autor:
Ochenduszko, Sebastian, García Sanchez, Javier, Fita, María José Juan, González‐Barrallo, Inés, Herrero Colomina, Julio, Mujika, Karmele, Beveridge, Roberto Diaz, Martínez, Silverio Ros, Lafuente, Blanca Sánchez, Tomas, Alberto Cunquero, Jaime, Alfonso Berrocal, Cerezuela Fuentes, Pablo, Fra, Pablo Luna, Peeters, Alicia Gervás, Meana García, José Andrés, García, María Asunción Algarra, Altozano, Javier Perez, Cancela, Maria, Puchades, Almudena Mateu, Roca, Francisco Ferrando
Publikováno v:
Pigment Cell & Melanoma Research; Sep2023, Vol. 36 Issue 5, p388-398, 11p
Autor:
Maria, Gonzalez-Cao, Teresa, Puertolas, Clara, Martinez-Vila, Cristina, Carrera, Cayetana, Maldonado Seral, Pedro, Rodríguez-Jiménez, Silvia, Sequero, Pablo, Cerezuela-Fuentes, Rosa, Feltes Ochoa, Eva, Muñoz, Mónica, Antoñanzas Basa, Juan, Martín-Liberal, Ainara, Soria, Juan, Francisco Rodriguez Moreno, Ivan, Marquez-Rodas, Pilar, Lopez Criado, José, Luis Manzano, Rafael, Lopez-Castro, Pablo, Ayala de Miguel, Laura, Villalobos, Salvador, Martin Algarra, Ines, Gonzalez-Barrallo, Aram, Boada, Almudena, García Castaño, Susana, Puig, Guillermo, Crespo, Pablo, Luna Fra, Cristina, Aguayo Zamora, Marta, Feito Rodríguez, Lara, Valles, Ana, Drozdowskyj, Jesús, Gardeazabal, Luis, Antonio Fernandez-Morales, Alberto, Rodrigo, Raquel, Cruz, Oriol, Yelamos, Belen, Rubio, Karmele, Mujica, Mariano, Provencio, Alfonso, Berrocal
Background The Spanish Melanoma Group (GEM) developed a national registry of patients with melanoma infected by SARS-CoV-2 ( GRAVID ).Methods The main objective was to describe the COVID-19 fatality rate in patients with melanoma throughout the pande
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0f3f41e0e5a020dbbf18dbcc0d240b01
https://hdl.handle.net/10171/65982
https://hdl.handle.net/10171/65982
Autor:
Clara Mayo de las Casas, Maria Gonzalez-Cao, Sebastian Ochenduszko, Juana Oramas, Miguel Angel Molina, Eva Muñoz-Couselo, Ana Arance, Roberto Diaz Beveridge, Miguel A Berciano-Guerrero, Enrique Espinosa, Luis de la Cruz, Delvys Rodriguez, Pablo Cerezuela, Ana Drozdowskyj, L. Bellido, Clara Montagut, Teresa Puertolas, Laura Basterretxea, Jose A. Lopez-Martin, Alfonso Berrocal, Maria-Jose Villanueva, Begoña Campos
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Nature Communications
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
NATURE COMMUNICATIONS
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Nature Communications
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
NATURE COMMUNICATIONS
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Combination treatment with BRAF (BRAFi) plus MEK inhibitors (MEKi) has demonstrated survival benefit in patients with advanced melanoma harboring activating BRAF mutations. Previous preclinical studies suggested that an intermittent dosing of these d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8921227b4094a6e83648a83acb6fbd70
https://doaj.org/article/bcf9c314e06143fd83f1b0b564d0166e
https://doaj.org/article/bcf9c314e06143fd83f1b0b564d0166e